Whole Body Nitric Oxide Synthesis in Healthy Men Determined from [$^{15}$N]arginine-to-[$^{15}$N]citrulline Labeling
The rates of whole body nitric oxide (NO) synthesis, plasma arginine flux, and de novo arginine synthesis and their relationships to urea production, were examined in a total of seven healthy adults receiving an L-amino acid diet for 6 days. NO synthesis was estimated by the rate of conversion of th...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 93; no. 21; pp. 11460 - 11465 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences of the United States of America
15.10.1996
National Acad Sciences |
Subjects | |
Online Access | Get full text |
ISSN | 0027-8424 1091-6490 |
DOI | 10.1073/pnas.93.21.11460 |
Cover
Abstract | The rates of whole body nitric oxide (NO) synthesis, plasma arginine flux, and de novo arginine synthesis and their relationships to urea production, were examined in a total of seven healthy adults receiving an L-amino acid diet for 6 days. NO synthesis was estimated by the rate of conversion of the [$^{15}$N]guanidino nitrogen of arginine to plasma [$^{15}$N]ureido citrulline and compared with that based on urinary nitrite (NO$_{2}^{-}$)/nitrate (NO$_{3}^{-}$) excretion. Six subjects received on dietary day 7, a 24-hr (12-hr fed/12-hr fasted) primed, constant, intravenous infusion of L-[guanidino- $^{15}$N$_{2}$]arginine and [$^{13}$C]urea. A similar investigation was repeated with three of these subjects, plus an additional subject, in which they received L-[ureido-$^{13}$C]citrulline, to determine plasma citrulline fluxes. The estimated rates (mean $\pm $ SD) of NO synthesis over a period of 24 hr averaged 0.96 $\pm $ 0.1 $\mu $mol$\cdot $kg$^{-1}\cdot $hr$^{-1}$ and 0.95 $\pm $ 0.1 $\mu $mol$\cdot $kg$^{-1}\cdot $hr$^{-1}$, for the [$^{15}$N]citrulline and the nitrite/nitrate methods, respectively. About 15% of the plasma arginine turnover was associated with urea formation and 1.2% with NO formation. De novo arginine synthesis averaged 9.2 $\pm $ 1.4 $\mu $mol$\cdot $kg$^{-1}\cdot $hr$^{-1}$, indicating that $\approx $11% of the plasma arginine flux originates via conversion of plasma citrulline to arginine. Thus, the fraction of the plasma arginine flux associated with NO and also urea synthesis in healthy humans is small, although the plasma arginine compartment serves as a significant precursor pool (54%) for whole body NO formation. This tracer model should be useful for exploring these metabolic relationships in vivo, under specific pathophysiologic states where the L-arginine-NO pathway might be altered. |
---|---|
AbstractList | The rates of whole body nitric oxide (NO) synthesis, plasma arginine flux, and de novo arginine synthesis and their relationships to urea production, were examined in a total of seven healthy adults receiving an L-amino acid diet for 6 days. NO synthesis was estimated by the rate of conversion of the [15N] guanidino nitrogen of arginine to plasma [15N] ureido citrulline and compared with that based on urinary nitrite (NO2-)/nitrate (NO3-) excretion. Six subjects received on dietary day 7, a 24-hr (12-hr fed/12-hr fasted) primed, constant, intravenous infusion of L-[guanidino-15N2]arginine and [13C]urea. A similar investigation was repeated with three of these subjects, plus an additional subject, in which they received L-[ureido-13C]citrulline, to determine plasma citrulline fluxes. The estimated rates (mean +/- SD) of NO synthesis over a period of 24 hr averaged 0.96 +/- 0.1 mumol .kg-1.hr-1 and 0.95 +/- 0.1 mumol.kg-1.hr-1, for the [15N]citrulline and the nitrite/nitrate methods, respectively. About 15% of the plasma arginine turnover was associated with urea formation and 1.2% with NO formation. De novo arginine synthesis averaged 9.2 +/- 1.4 mumol. kg-1.hr-1, indicating that approximately 11% of the plasma arginine flux originates via conversion of plasma citrulline to arginine. Thus, the fraction of the plasma arginine flux associated with NO and also urea synthesis in healthy humans is small, although the plasma arginine compartment serves as a significant precursor pool (54%) for whole body NO formation. This tracer model should be useful for exploring these metabolic relationships in vivo, under specific pathophysiologic states where the L-arginine-NO pathway might be altered. The rates of whole body nitric oxide (NO) synthesis, plasma arginine flux, and de novo arginine synthesis and their relationships to urea production, were examined in a total of seven healthy adults receiving an L-amino acid diet for 6 days. NO synthesis was estimated by the rate of conversion of the [$^{15}$N]guanidino nitrogen of arginine to plasma [$^{15}$N]ureido citrulline and compared with that based on urinary nitrite (NO$_{2}^{-}$)/nitrate (NO$_{3}^{-}$) excretion. Six subjects received on dietary day 7, a 24-hr (12-hr fed/12-hr fasted) primed, constant, intravenous infusion of L-[guanidino- $^{15}$N$_{2}$]arginine and [$^{13}$C]urea. A similar investigation was repeated with three of these subjects, plus an additional subject, in which they received L-[ureido-$^{13}$C]citrulline, to determine plasma citrulline fluxes. The estimated rates (mean $\pm $ SD) of NO synthesis over a period of 24 hr averaged 0.96 $\pm $ 0.1 $\mu $mol$\cdot $kg$^{-1}\cdot $hr$^{-1}$ and 0.95 $\pm $ 0.1 $\mu $mol$\cdot $kg$^{-1}\cdot $hr$^{-1}$, for the [$^{15}$N]citrulline and the nitrite/nitrate methods, respectively. About 15% of the plasma arginine turnover was associated with urea formation and 1.2% with NO formation. De novo arginine synthesis averaged 9.2 $\pm $ 1.4 $\mu $mol$\cdot $kg$^{-1}\cdot $hr$^{-1}$, indicating that $\approx $11% of the plasma arginine flux originates via conversion of plasma citrulline to arginine. Thus, the fraction of the plasma arginine flux associated with NO and also urea synthesis in healthy humans is small, although the plasma arginine compartment serves as a significant precursor pool (54%) for whole body NO formation. This tracer model should be useful for exploring these metabolic relationships in vivo, under specific pathophysiologic states where the L-arginine-NO pathway might be altered. |
Author | Castillo, Leticia Young, Vernon R. Ajami, Alfred M. Beaumier, Louis |
AuthorAffiliation | Laboratory of Human Nutrition, Massachusetts Institute of Technology, Cambridge 02139, USA |
AuthorAffiliation_xml | – name: Laboratory of Human Nutrition, Massachusetts Institute of Technology, Cambridge 02139, USA |
Author_xml | – sequence: 1 givenname: Leticia surname: Castillo fullname: Castillo, Leticia – sequence: 2 givenname: Louis surname: Beaumier fullname: Beaumier, Louis – sequence: 3 givenname: Alfred M. surname: Ajami fullname: Ajami, Alfred M. – sequence: 4 givenname: Vernon R. surname: Young fullname: Young, Vernon R. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8876157$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9vFCEcxYmpqdvq3ZgYOfTgZdYvDDMDSS9af9RkbQ9qPBglDAO7NLOwAWq6Mf7vsu62Wg89Ad_3Pi_AO0B7PniD0GMCUwJd_WLlVZqKekrJlBDWwj00ISBI1TIBe2gCQLuKM8oeoIOULgBANBz20T7nXUuaboLyl0UYDX4VhjU-czk6jc-v3GDwx7XPC5Ncws7jU6PGvFjjD8bj1yabuHTeDNjGsMRfj77_JM2vo7NvKs6dL0KVQ_V3qkvq5TiWOZ6p3pTN_CG6b9WYzKPdeog-v33z6eS0mp2_e3_yclZp1vBctZQKwrlqeW_VYKHWTJNOc6qIttbWtNeaUuCWdaI3YKAlwojOKhCiK8f6EB1vc1eX_dIM2vgc1ShX0S1VXMugnLyteLeQ8_BD1hw6UfCn_-I33O7zit5udR1DStFYWd6qsgubMDdKAnJTktyUJEUtKZF_Siog_AdeR9-BPNvdZaNc2287nt_tkLbUkM1VLtYnW-tFyiHeeBmwpq1_A-pjuGw |
CitedBy_id | crossref_primary_10_1079_NRR200490 crossref_primary_10_1620_tjem_199_95 crossref_primary_10_1016_S0009_9120_98_00015_0 crossref_primary_10_1177_01486071050290S1S70 crossref_primary_10_1016_j_thromres_2004_09_003 crossref_primary_10_1016_S0891_5849_98_00184_1 crossref_primary_10_1111_j_1365_2230_2004_01627_x crossref_primary_10_1159_000018061 crossref_primary_10_1006_jsre_2000_5867 crossref_primary_10_3945_ajcn_2007_25765 crossref_primary_10_1152_ajpendo_00481_2006 crossref_primary_10_1016_j_jpeds_2013_01_005 crossref_primary_10_1016_j_ab_2003_11_006 crossref_primary_10_1111_j_1572_0241_2007_01239_x crossref_primary_10_1186_ar2030 crossref_primary_10_1016_j_pharmthera_2007_08_001 crossref_primary_10_1097_01_fpc_0000167328_85163_44 crossref_primary_10_1016_j_advms_2018_08_018 crossref_primary_10_1093_jn_130_7_1835S crossref_primary_10_1111_j_1440_1681_2004_04060_x crossref_primary_10_3945_ajcn_111_032045 crossref_primary_10_1097_01_CCM_0000142939_81045_A0 crossref_primary_10_1054_clnu_2001_0513 crossref_primary_10_1152_ajpendo_00252_2005 crossref_primary_10_1016_S0301_2115_00_00334_1 crossref_primary_10_1006_niox_2000_0276 crossref_primary_10_1097_MCO_0b013e328332f99d crossref_primary_10_1016_j_clnu_2008_04_014 crossref_primary_10_1093_ajcn_79_2_185 crossref_primary_10_1016_j_clnu_2003_09_003 crossref_primary_10_1203_PDR_0b013e318179454b crossref_primary_10_1016_j_jchromb_2008_01_055 crossref_primary_10_1016_j_jpba_2010_11_023 crossref_primary_10_1097_00075197_200203000_00012 crossref_primary_10_1073_pnas_96_16_9027 crossref_primary_10_1186_1472_6890_9_10 crossref_primary_10_1074_jbc_M806654200 crossref_primary_10_1016_j_burns_2010_06_003 crossref_primary_10_1111_apha_13637 crossref_primary_10_1016_j_mam_2021_101056 crossref_primary_10_1038_sj_bjp_0701553 crossref_primary_10_1097_00003246_200203000_00003 crossref_primary_10_1161_01_ATV_0000075300_76279_BB crossref_primary_10_1371_journal_pone_0200489 crossref_primary_10_1016_S0304_4165_01_00227_6 crossref_primary_10_1038_emm_2015_97 crossref_primary_10_3803_EnM_2020_406 crossref_primary_10_2527_2006_8413_supplE60x crossref_primary_10_1016_j_jhep_2010_06_042 crossref_primary_10_1152_ajprenal_0039_2001 crossref_primary_10_1016_j_molmed_2020_06_006 crossref_primary_10_1172_JCI82925 crossref_primary_10_1515_CCLM_2001_137 crossref_primary_10_1203_PDR_0b013e318176180e crossref_primary_10_1007_s40746_022_00252_z crossref_primary_10_3390_nu11071452 crossref_primary_10_1177_0148607109347897 crossref_primary_10_1111_bph_13269 crossref_primary_10_1046_j_1365_2281_1999_00212_x crossref_primary_10_1080_00365520500442724 crossref_primary_10_1152_ajpendo_00284_2012 crossref_primary_10_1016_j_jchromb_2006_08_054 crossref_primary_10_1161_JAHA_112_004309 crossref_primary_10_1152_ajprenal_00340_2015 crossref_primary_10_1089_ars_2017_7083 crossref_primary_10_3945_ajcn_112_048025 crossref_primary_10_1007_s00018_021_03828_4 crossref_primary_10_1128_IAI_00655_18 crossref_primary_10_3945_jn_111_153825 crossref_primary_10_1093_ajcn_nqz039 crossref_primary_10_1254_jphs_93_409 crossref_primary_10_1016_S0012_3692_15_34465_2 crossref_primary_10_1006_abio_1997_2515 crossref_primary_10_1093_jn_134_10_2768S crossref_primary_10_1016_j_clnu_2008_02_005 crossref_primary_10_1016_j_metabol_2017_09_015 crossref_primary_10_1126_sciadv_abg1964 crossref_primary_10_1152_ajpendo_00004_2002 crossref_primary_10_1093_jn_137_6_1383 crossref_primary_10_1177_15648265020233S122 crossref_primary_10_1097_00075197_200301000_00015 crossref_primary_10_1152_ajpgi_00461_2007 crossref_primary_10_1093_jn_137_6_1662S crossref_primary_10_1097_01_mco_0000222104_23171_58 crossref_primary_10_3945_ajcn_115_125187 crossref_primary_10_1016_S0002_9610_02_00815_2 crossref_primary_10_1172_JCI7199 crossref_primary_10_1021_ac9019208 crossref_primary_10_1079_PNS19990004 crossref_primary_10_1074_jbc_M000532200 crossref_primary_10_1111_apha_13937 crossref_primary_10_1152_ajpgi_00375_2024 crossref_primary_10_1146_annurev_nutr_22_110901_145329 crossref_primary_10_1089_neu_2011_2029 crossref_primary_10_1152_ajpendo_00525_2007 crossref_primary_10_1038_sj_bjp_0704993 crossref_primary_10_1021_jasms_1c00055 crossref_primary_10_1079_PNS200067 crossref_primary_10_1093_clinchem_43_4_553 crossref_primary_10_1080_10256016_2013_828718 crossref_primary_10_1007_s00726_016_2344_7 crossref_primary_10_1152_ajpendo_00290_2007 crossref_primary_10_1016_j_jchromb_2006_07_018 crossref_primary_10_1177_1535370219900637 crossref_primary_10_1002_cbic_200500359 crossref_primary_10_1152_ajpendo_00055_2008 crossref_primary_10_1093_jn_133_6_2034S crossref_primary_10_3945_jn_110_129403 crossref_primary_10_1042_CS20080444 crossref_primary_10_1039_b701992k crossref_primary_10_1093_jn_134_10_2798S crossref_primary_10_1097_MNH_0b013e32835a6ff7 crossref_primary_10_3945_ajcn_2009_27812 crossref_primary_10_1039_C4CP02514H crossref_primary_10_1152_ajpendo_2001_280_3_E509 crossref_primary_10_1054_clnu_2002_0571 crossref_primary_10_1053_ajkd_2002_29917 crossref_primary_10_1016_j_nrleng_2017_07_005 crossref_primary_10_1097_SPC_0000000000000560 crossref_primary_10_1093_jn_nxaa318 crossref_primary_10_1016_S1155_1941_08_48996_5 crossref_primary_10_1097_01_CCM_0000278600_14265_95 crossref_primary_10_1152_ajpgi_00257_2023 crossref_primary_10_2337_diabetes_52_3_795 crossref_primary_10_3390_nu14122480 crossref_primary_10_1038_srep37005 crossref_primary_10_1007_s00268_003_7396_7 crossref_primary_10_1152_ajpendo_00399_2012 crossref_primary_10_1161_01_ATV_19_5_1168 crossref_primary_10_1111_apha_13572 crossref_primary_10_1113_jphysiol_2006_126029 crossref_primary_10_1016_j_freeradbiomed_2011_05_032 crossref_primary_10_1111_apha_13443 crossref_primary_10_1016_j_nrl_2017_07_013 crossref_primary_10_1073_pnas_96_18_9967 crossref_primary_10_1006_niox_2000_0328 crossref_primary_10_1016_j_clnu_2016_12_023 crossref_primary_10_1016_j_clnu_2010_02_005 crossref_primary_10_3945_ajcn_112_042523 crossref_primary_10_1097_HJH_0b013e3283487806 crossref_primary_10_1016_S0002_9610_02_00847_4 crossref_primary_10_1177_1358863X08100834 crossref_primary_10_1093_jn_nxx032 crossref_primary_10_1097_01_CCM_0000050291_37714_74 crossref_primary_10_1042_CS20070143 crossref_primary_10_1093_jn_134_10_2748S crossref_primary_10_1152_ajpendo_00339_2015 crossref_primary_10_2165_11538590_000000000_00000 crossref_primary_10_3390_nu7031426 crossref_primary_10_1016_S0753_3322_02_00284_6 crossref_primary_10_1155_2016_1373060 crossref_primary_10_7554_eLife_43718 crossref_primary_10_1002_brb3_1520 crossref_primary_10_12997_jla_2020_9_1_110 crossref_primary_10_3168_jds_2018_14879 crossref_primary_10_1111_j_1748_1716_2006_01612_x crossref_primary_10_1021_mp5001372 crossref_primary_10_1161_01_ATV_0000040860_71626_9D crossref_primary_10_3945_jn_116_240382 crossref_primary_10_1093_ajcn_85_1_167 crossref_primary_10_3390_nu8050311 crossref_primary_10_1017_S0007114511006660 crossref_primary_10_1152_ajpgi_00289_2007 crossref_primary_10_3390_s151025992 crossref_primary_10_1161_HYPERTENSIONAHA_114_03519 crossref_primary_10_1093_ajcn_87_5_1282 crossref_primary_10_1080_10715762_2019_1587168 |
ContentType | Journal Article |
Copyright | Copyright 1996 National Academy of Sciences |
Copyright_xml | – notice: Copyright 1996 National Academy of Sciences |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 5PM |
DOI | 10.1073/pnas.93.21.11460 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 11465 |
ExternalDocumentID | PMC38079 8876157 10_1073_pnas_93_21_11460 93_21_11460 40456 |
Genre | Research Support, U.S. Gov't, P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: GM 02700 – fundername: NCRR NIH HHS grantid: RR80 – fundername: NIDDK NIH HHS grantid: DK 15856 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACHIC ACIWK ACKIV ACNCT ACPRK ADQXQ ADULT ADXHL AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM AS~ CS3 D0L DCCCD DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HGD HH5 HQ3 HTVGU HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST KQ8 L7B LU7 MVM N9A NEJ NHB N~3 O9- OK1 P-O PNE PQQKQ R.V RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH W8F WH7 WHG WOQ WOW X7M XSW Y6R YKV YSK ZCA ZCG ~02 ~KM - 02 08R 0R 1AW 55 AAPBV ABFLS ABPTK ADACO ADZLD AFDAS AJYGW AS ASUFR DNJUQ DOOOF DWIUU DZ F20 GJ JSODD KM OHM PQEST RHF VQA X XFK XHC ZA5 AAYXX CITATION CGR CUY CVF ECM EIF NPM VXZ YIF YIN 5PM |
ID | FETCH-LOGICAL-c458t-6229188a68bfadf03c4c17c82a1cfff32bcc2208f479be0e0619e97fa09970e03 |
ISSN | 0027-8424 |
IngestDate | Thu Aug 21 18:13:45 EDT 2025 Wed Feb 19 02:32:30 EST 2025 Tue Jul 01 04:10:55 EDT 2025 Thu Apr 24 22:57:28 EDT 2025 Wed May 29 08:07:26 EDT 2019 Wed Nov 11 00:29:11 EST 2020 Thu May 29 08:42:48 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c458t-6229188a68bfadf03c4c17c82a1cfff32bcc2208f479be0e0619e97fa09970e03 |
PMID | 8876157 |
PageCount | 6 |
ParticipantIDs | crossref_citationtrail_10_1073_pnas_93_21_11460 pubmedcentral_primary_oai_pubmedcentral_nih_gov_38079 pnas_primary_93_21_11460 crossref_primary_10_1073_pnas_93_21_11460 jstor_primary_40456 pubmed_primary_8876157 pnas_primary_93_21_11460_fulltext |
ProviderPackageCode | RNA PNE CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 19961015 1996-10-15 1996-Oct-15 |
PublicationDateYYYYMMDD | 1996-10-15 |
PublicationDate_xml | – month: 10 year: 1996 text: 19961015 day: 15 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 1996 |
Publisher | National Academy of Sciences of the United States of America National Acad Sciences |
Publisher_xml | – name: National Academy of Sciences of the United States of America – name: National Acad Sciences |
SSID | ssj0009580 |
Score | 1.9603333 |
Snippet | The rates of whole body nitric oxide (NO) synthesis, plasma arginine flux, and de novo arginine synthesis and their relationships to urea production, were... |
SourceID | pubmedcentral pubmed crossref pnas jstor |
SourceType | Open Access Repository Index Database Enrichment Source Publisher |
StartPage | 11460 |
SubjectTerms | Adult Arginine - blood Arginine - metabolism Biological sciences Blood plasma Citrulline - blood Citrulline - metabolism Eating Excretion Fasting Humans Isotope Labeling Isotopic abundance Male Metabolism Models, Biological Nitrates Nitrates - urine Nitric Oxide - biosynthesis Nitrites - urine Nitrogen Nitrogen Isotopes Oxides Time Factors Urine Urine specimen collection |
Title | Whole Body Nitric Oxide Synthesis in Healthy Men Determined from [$^{15}$N]arginine-to-[$^{15}$N]citrulline Labeling |
URI | https://www.jstor.org/stable/40456 http://www.pnas.org/content/93/21/11460.abstract https://www.ncbi.nlm.nih.gov/pubmed/8876157 https://pubmed.ncbi.nlm.nih.gov/PMC38079 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKeOEFscG08iUjNRJTlS5xkiZ53BdMaCsTbDAJQWW7DgRtGVpbiYL41fwB7rWdL9gm4CVqHCdKck_tk-ScewnpwSQh2CTz3aH0PBdLFLqCB8zlTKgggAFQ6JIsB6Ph3nH44iQ66XR-NlRL85kYyG-X-kr-J6rQBnFFl-w_RLY6KDTAb4gvLCHCsPyrGL_F4rb9rfPJAiKKqfb7L7_mE9V_vSiA12GqEZ3JChVeC9SvwuhixC_AMrWvxIm2HBY60a4Tb_mRE-_A2siJdvjFRywcodzZuXtVH4l-jVPNUve50Lb2JtM9rGbGaalDGJUvHjdrG4sdW6Z9t384qosib3MYeuxnoX30Web1iwPF52e5Qdr--TyvHgo2P_Oz3Jh2MlTVHwz-GNLeqIsC4P5qUL_s0Ppo1I5EtRbkuvO019Li6prOm09fzVmAwcwcGu92OQuYOo0W7ca0bcd09G17DYKA69Glsw8Ml1gyueDTQRoMmD9o7NrK6R0ikb5BbrI41tqC5yd-I1N0YnxT9iTtt3U49sbvR25xKSOnxRy90KvBp9pa3wZ5OrpDbtunHrppILxMOqpYIcvlPaVPbfLz9btkpjFNEdPUYJpqTNMK0zQvqMU0BUzTGtMUMU3f9T5896MfvdH7Jorr1hq3tMTtPXL8bPdoe8-1lUFcGUbJzB0ylvpJwoeJyPgk8wIZSj-WCeO-zLIsYEJKxrwkC-NUKE8BaU1VGmccfeKwGqySJYCbWsOcBRyInODDSKZAGpRgwhsmWSxTlk2UCrtko7zHY2nT5mP1ltOxlm_EwRjv9zgNxszXFn-vS9arPb6YlDHX9F3RYas6amR0yZruWDa2dnhy1aZxZuViXbJqYl71AiYBTy5xl0QtMFTbMcd8e0uRf9K55rEeRXr_0rN8QG7Vf9GHZAmCpx4BQ5-JxxrRvwBpIeQK |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Whole+Body+Nitric+Oxide+Synthesis+in+Healthy+Men+Determined+from+%5B%24%5E%7B15%7D%24N%5Darginine-to-%5B%24%5E%7B15%7D%24N%5Dcitrulline+Labeling&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Castillo%2C+Leticia&rft.au=Beaumier%2C+Louis&rft.au=Ajami%2C+Alfred+M.&rft.au=Young%2C+Vernon+R.&rft.date=1996-10-15&rft.pub=National+Academy+of+Sciences+of+the+United+States+of+America&rft.issn=0027-8424&rft.volume=93&rft.issue=21&rft.spage=11460&rft.epage=11465&rft_id=info:doi/10.1073%2Fpnas.93.21.11460&rft.externalDocID=40456 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F93%2F21.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F93%2F21.cover.gif |